Skip to main content
NGVT logo

NGVT · Ingevity Corp

Track NGVT — free
$70.75 -0.31 (-0.44%) At close · Sep 30
Market Cap
$2.51B
Shares
34.38M
Volume · Sep 30 406.18K Avg daily vol (3M) 246.27K

Price & Indicators

Drag to pan · scroll to zoom
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$70.75 Open$71.42 Day$69.81–71.42 52W close$46.20–77.87 Avg vol 30d259K Short int1.4M · 4.2% float · 6.1d Short vol72% Last earningsJul 30, 2026 DataJan 2020–Sep 2026 Filing10-Q · Jul 30

Up next

Next earnings call
Oct 27, 2026 Est · unconfirmed · in 4 wks
filed Jul 30, 2026
call held Jul 30, 2026

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$1.16B
Trailing 12 months
Net income (TTM)
$54.00M
Trailing 12 months
Revenue growth YoY
-5.2%
Year over year
Operating margin
35.9%
Trailing 12 months
P / E (TTM)
47.1
Trailing earnings · reciprocal yield 2.1%
FCF yield
6.2%
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
−$46.60M
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
-3.2%
Year over year · fewer shares
Price change (1Y)
+30.4%
Trailing year
Short interest
4.2%
Latest settlement · 6.1 days to cover
View all 115 metrics

AI Brief

Q2 FY26 earnings call · Jul 30, 2026
Q2 FY26

TL;DR. Ingevity reported broad underlying growth and sharply higher profitability, with adjusted EBITDA up 14% to $115.0 million and margin expanding to 36.6%, while raising full-year adjusted EBITDA guidance to $380–$400 million. The second half is expected to be tempered by weaker North American auto production, planned plant outages, and a dynamic macroeconomic environment.

Bullish
  • + Sales excluding Road Markings increased 5%, with growth across all three segments.
  • + Performance Materials delivered 4% sales growth to $160.6 million and 6% EBITDA growth to $86.1 million, with margin expanding to 53.6%.
  • + Advanced Polymer Technologies sales increased 14% to $49.3 million and EBITDA rose to $11.2 million from $2.0 million.
Bearish
  • − Reported sales declined 5% to $314.1 million, primarily because of the Road Markings divestiture.
  • − Pavement Technologies EBITDA declined $3.4 million to $25.4 million because prior-year results included $6.0 million of Road Markings EBITDA.
  • − The company expects second-half Performance Materials profitability to face pressure from weaker auto production and planned maintenance outages.
  • − Pavement Technologies faced softer demand in China and South America as higher asphalt prices increased project costs and delayed projects.
  • − Advanced Polymer Technologies benefited from competitor supply disruptions that are expected to normalize.
  • − Second-quarter operating cash flow was negative $13.8 million after a $113.2 million litigation settlement payment.

AI-generated from the earnings call and 8-K · may contain errors · not investment advice

Equibles Rating

blended score · not investment advice
Overall
Neutral
SellHoldBuy
Technical Buy Momentum Neutral Sentiment Neutral Fundamentals Fair Quant / Vol Moderate
Market backdrop VIX 16.3 · calm Equity put/call 0.53
Technical
price trend
Buy
50 / 200-day cross No cross
Price vs 200-day avg +1%
above
Price vs 50-day avg −1%
below
RSI (14) 51
neutral
MACD trend Positive
52-week position 78%
mid-range
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Neutral
1-month return +3%
trailing
6-month return −6%
trailing
YTD return +20%
this year
Relative strength −18%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $72 › 200d $70 — 50d above 200d
Institutional flow Accumulating
+3% holders QoQ · +47 funds added
Insider flow Distributing
Net -$199.7K over 90 days · 100% sells
Short interest Rising
4.20% of float · ▲ +9.7% MoM · 6.1 days cover
Volume signal Reversal watch
High volume on a down day — possible exhaustion
Institution breadth Multi-yr high
316 holders — near 3-yr high, broad support
Squeeze score 68
elevated · 0–100
Fundamentals
Fair
Revenue growth −3%
Y/Y
Gross margin 40%
expanding
EPS growth +61%
Y/Y
Free cash flow $249.1M
Valuation P/E 48.3
rich
Buyback $211.0M
remaining
Balance sheet $1.0B
net debt
Quant / Vol
risk profile
Moderate
Volatility 36%
annualized · 1-yr
Max drawdown −19%
past year
ATR 2.9%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Beat or met 3 of last 4
Latest guidance · from the 8-K filed Jul 29, 2026
Adjusted EBITDA · full year 2026 Non-GAAP Initiated $380M – $400M
Diluted adjusted EPS · full year 2026 Non-GAAP Initiated $5.00 – $5.45
Free cash flow · full year 2026 Non-GAAP Initiated $220M – $245M
Guided vs delivered · last 4 settled
Sales full year 2024
guided $1.4B – $1.5B
$1.2B Miss −17.2%
Sales 2022
guided $1.53B – $1.6B
$1.67B Beat +6.8%
Sales full year 2021
guided $1.32B – $1.36B
$1.39B Beat +3.8%
Sales fiscal year 2020
guided $1.15B – $1.2B
$1.22B Beat +3.5%

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Buy
0 · 5 · 2
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
+1% Bullish
Price vs 50-day avg
−1% Neutral
RSI (14)
51 Neutral
MACD trend
Positive Bullish
52-week position
78% Neutral
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross) No cross
50d $72 › 200d $70 — 50d above 200d
Institutional flow Accumulating
+3% holders QoQ · +47 funds added
Insider flow Distributing
Net -$199.7K over 90 days · 100% sells
Short interest Rising
4.20% of float · ▲ +9.7% MoM · 6.1 days cover
Volume signal Reversal watch
High volume on a down day — possible exhaustion
Institution breadth Multi-yr high
316 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $46 Now $71 · 78% Range high $78
vs 200-day avg +1% vs 50-day avg -1%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

Earlier KPI extraction records exist, but do not meet the current evidence-completeness requirements. No current verified series is available. Earlier figures remain withheld until revalidated; this is not evidence that the company reports no KPIs.

Versus peers

Specialty Chemicals — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
NGVT
Ingevity Corp
this stock
$2.51B +19.6% -2.7% 48.3 4.2%
LIN
Linde PLC
$216.61B +11.3% +3.0% 30.3 1.3%
AIQUF
L Air Liquide SA /Fi
$121.25B +2.7% — — 0.0%
SHW
Sherwin Williams Co
$79.89B -0.2% +2.1% 30.4 2.6%
ECL
Ecolab Inc.
$78.35B +4.6% +2.2% 37.5 1.9%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Reducing
Holders
316
% held
102.2%
Net QoQ
-831.2K sh
Top holder
BlackRock, Inc.
Held Float
View
Held by Funds
Fund positions
339
View
Short & Settlement
Short Interest Rising
Shares short
1.4M
Days to cover
6.1d
Change
+127.4K sh
View
Short Volume
Short vol %
72%
As of
Sep 30, 2026
Short Total
View
Fails to Deliver
FTD shares
5.1K
Value
$355.8K
As of
Sep 14, 2026
View
Off-Exchange
Off-exchange %
37.0%
Week of
Aug 24, 2026
Off-exch Lit
View
Smart Money
Insider Trades Net selling
Net (90d)
-$199.7K
Buyers / Sellers
0 / 1
Buyers Sellers
View
Financials
Financials
Revenue (FY)
$1.2B
Net income (FY)
$-167.1M
EPS diluted
$-4.61
View
Buybacks
Authorized
$500.0M
Remaining
$211.0M
Spent Remaining
View
Filings
SEC Filings
Latest
10-Q
Filed
Jul 30, 2026
This year
14
View
Proposed Sales
Value
$1.6M
Shares
20.1K
Filed
Aug 12, 2026
View
Earnings & Events
Earnings Calls
Last call
Jul 30, 2026
View
Investor Relations
Latest news
Ingevity’s Evotherm® P35 receives…
Published
Jul 16, 2026
View

Performance

5D 20D 120D MTD YTD
NGVT -1.4% +3.3% -5.6% +2.1% +19.6%
SPY -0.7% +0.1% +12.2% -0.6% +11.8%
vs SPY -0.7% +3.2% -17.8% +2.7% +7.7%

Capital returns

Buyback program · as of Jul 29, 2026
Authorized
$500.00M
Spent (derived)
$289.00M
Remaining
$211.00M
Spent Remaining

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 1653477 CUSIP 45688C107 13F (30d) 11 filings 9 filers Visit website Investor relations